Archer-Daniels-Midland Co Equity Method Investment, Other than Temporary Impairment
Archer-Daniels-Midland Co (ADM) reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-18.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2021-02-18
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for the quarter ending 2018-12-31 was $0.00.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for the quarter ending 2018-09-30 was $0.00.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for the quarter ending 2018-06-30 was $0.00.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for the quarter ending 2018-03-31 was $12.00M.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for fiscal 2020 was $0.00.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for fiscal 2018 was $12.00M.
- Archer-Daniels-Midland Co equity method investment, other than temporary impairment for fiscal 2017 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-18 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-02-18 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | $12.00M 10-K · filed 2021-02-18 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $12.00M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $12.00M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $12.00M 10-Q · filed 2019-04-26 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-18 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-19 | |||
| 2014-12-31 | $0.00 10-K · filed 2015-02-20 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-02-20 | |||
| 2012-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2015-02-20 | $146.00M 10-K · filed 2015-02-20 | $146.00M 10-K · filed 2014-02-26 | |
| 2012-09-30 | $146.00M 10-Q · filed 2013-11-01 | $146.00M 10-Q · filed 2013-11-01 | ||
| 2012-06-30 | $0.00 10-K · filed 2015-02-20 | |||
| 2011-12-31 | $0.00 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bunge Global SA (BG) | Switzerland | $21.391B | 36.03 |
| DARLING INGREDIENTS INC. (DAR) | United States | $9.740B | 15.03 |